Vertex Revenue and Competitors
Estimated Revenue & Valuation
- Vertex's estimated annual revenue is currently $318.9M per year.
- Vertex's estimated revenue per employee is $203,000
Employee Data
- Vertex has 1571 Employees.
Vertex's People
Name | Title | Email/Phone |
---|---|---|
1 | President, CEO and Chairperson the Board | Reveal Email/Phone |
2 | Chief Strategy Officer (CSO) | Reveal Email/Phone |
3 | Chief Economist & Senior Tax Policy Director | Reveal Email/Phone |
4 | Chief Accounting Officer (CAO) | Reveal Email/Phone |
5 | VP Indirect Tax Solutions Line Business | Reveal Email/Phone |
6 | VP, Revenue Operations and Enablement | Reveal Email/Phone |
7 | VP SAP Business Development | Reveal Email/Phone |
8 | VP Technology Strategy | Reveal Email/Phone |
9 | Head European Marketing | Reveal Email/Phone |
10 | VP Global Channel Sales at Vertex Inc. | Reveal Email/Phone |
Vertex Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $9.5M | 44 | N/A | N/A | N/A |
#2 | $195M | 4970 | 4% | $341M | $9.5B |
#3 | $0.1M | 1 | 0% | N/A | N/A |
#4 | $475M | 2600 | 0% | N/A | N/A |
#5 | $4330M | 19268 | N/A | N/A | $45.1B |
#6 | $3937.2M | 19395 | N/A | N/A | N/A |
#7 | $77.7M | 444 | N/A | N/A | N/A |
#8 | $535.4M | 2880 | 0% | $746.1M | $10B |
#9 | $14.3M | 102 | 4% | $91.8M | N/A |
#10 | $27.3M | 136 | N/A | N/A | N/A |
#11 | $406.1M | 1967 | -2% | $220M | $5.2B |
#12 | $169.4M | 846 | 23% | $303M | $1.2B |
#13 | $104.6M | 568 | 3% | $7.5M | N/A |
#14 | $308.5M | 3430 | 16% | $279.7M | $18.6B |
#15 | $6.9M | 53 | N/A | N/A | N/A |
#16 | $1M | 8 | N/A | N/A | N/A |
#17 | $39M | 253 | N/A | N/A | N/A |
#18 | $16.7M | 115 | N/A | N/A | N/A |
#19 | $13.5M | 104 | -9% | $24.9M | N/A |
#20 | $0.8M | 8 | N/A | N/A | N/A |
What Is Vertex?
N/A
Total Funding
1571
Number of Employees
$318.9M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Vertex News
2022-04-19 - The Zacks Analyst Blog Highlights Johnson & Johnson, Eli Lilly, Vertex
Pharmaceuticals and Deciphera Pharmaceuticals
Stocks recently featured in the blog include: Johnson & Johnson JNJ, Eli Lilly LLY, Vertex Pharmaceuticals VRTX and Deciphera...
2022-04-17 - Health Canada approves Vertex's Trikafta for cystic fibrosis in ...
Vertex's Trikafta was found to be well-tolerated in a Phase III trial in CF patients aged six to 11 years. Credit: Vertex Pharmaceuticals...
2022-04-06 - Vertex CEO Kewalramani nabs more than $15M in 2021 pay ...
In her first full year at the top of cystic fibrosis juggernaut Vertex Pharmaceuticals, CEO Reshma Kewalramani has collected a pay package that rivals...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $402.8M | 2004 | 19% | N/A |
#2 | $648.6M | 2106 | N/A | N/A |
#3 | $800.2M | 2117 | 3% | N/A |
#4 | $936.7M | 2478 | 5% | N/A |
#5 | $659.5M | 3249 | N/A | N/A |